The researchers (IMAGE) Aarhus University Caption The research groups led by Professor Martin Roelsgaard Jakobsen (right) and Associate Professor Rasmus Bak (left) have now clarified the key conditions needed to develop large numbers of the rare immune cells in a laboratory. Together with former postdoc Anders Laustsen, they have channeled the research into the newly started company UNIKUM Therapeutics, which aims to use pDCs for clinical therapeutic use. Photo: Simon Byrial Fischel Credit Photo: Simon Byrial Fischel Usage Restrictions No restrictions License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.